Glenmark Rating
GOLDMAN SACHS ON GLENMARK : 01.06.2021
* MAINTAIN NEUTRAL TARGET: 580
* Glenmark's Q4 In-line, expect steady growth in FY22, GS
* Q4 In-line, Expect Steady Growth In FY22
* Focussed On Launching Ryaltris Nasal Spray In More Markets
* Closing Out Outlicensing Agmts In Certain Innovative Pdts At Ichnos Sciences
MS ON GLENMARK : 01.06.2021
* MAINTAIN UNDERPERFORM TARGET: 554
* Glenmark's base business should maintain low double digit growth at 19-20% profitability, Morgan Stanley says, has an UNDERWEIGHT call on the stock
* Co Expects To Monetise Its NCE Pipeline In FY22
* NCE Pipeline Sale Should Help Release Free Cash Flow
* Base Business Should Maintain Low Double-digit Growth At 19-20% Profitability
CITI ON GLENMARK : 01.06.2021
* MAINTAIN BUY TARGET: 720
* Here's what Citi has to say about Glenmark after earnings
* FY21 Topline Was Muted At 3%
* Management Upbeat On Growing FY22 Revenue By 10%
* One-time Debt Reduction Up To $1,500 Cr Possible From Life Sciences
MACQUARIE ON GLENMARK : 01.06.2021
* Macquarie raises FY22/23E EPS estimates for Glenmark by 8/5%
* Free Cash Flow Prospects Are Looking Brighter In FY22
* MAINTAIN OUTPERFORM TARGET: 670
* 900-1,000 Cr Inflow Is Likely
* US Will Recover From FY21 Lows; India, Europe & API To Grow Well
* Raise FY22/23E EPS Estimates By 8/5%
